The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations
Open accessAbstract
Mutations in the tau gene are known to cosegregate with the disease in frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17). However, the molecular mechanism by which these mutations might lead to the disease is not understood. Here, we show that four of the FTDP-17 tau mutations, R406W, V337M, G272V, and P301L, result in tau proteins that are more favorable substrates for phosphorylation by brain protein kinases than the wild-type, largest four-repeat protein tau4L and tau4L more than tau3L. In general, at all the sites studied, mutant tau proteins were phosphorylated faster and to a higher extent than tau4L and tau4L > tau3L. The most dramatic difference found was in the rate and level of phosphorylation of tau4L(R406W) at positions Ser-396, Ser-400, Thr-403, and Ser-404. Phosphorylation of this mutant tau was 12 times faster and 400% greater at Ser-396 and less than 30% at Ser-400, Thr-403, and Ser-404 than phosphorylation of tau4L. The mutated tau proteins polymerized into filaments when 4-6 mol of phosphate per mol of tau were incorporated, whereas wild-type tau required approximately 10 mol of phosphate per mol of protein to self-assemble. Mutated and wild-type tau proteins were able to sequester normal tau upon incorporation of approximately 4 mol of phosphate per mol of protein, which was achieved at as early as 30 min of phosphorylation in the case of mutant tau proteins. These findings taken together suggest that the mutations in tau might cause neurodegeneration by making the protein a more favorable substrate for hyperphosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[6] Use of T7 RNA polymerase to direct expression of cloned genes
William Studier, F., Rosenberg, A. H., Dunn, J. J., & Dubendorff, J. W. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)85008-c · Cited by 6,562
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Self-citationAssociation of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Self-citationThe distribution of tau in the mammalian central nervous system.
Binder, L. I., Frankfurter, A., & Rebhun, L. I. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.4.1371 · Cited by 1,588
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371
Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036
von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5129 · Cited by 1,021
Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17
Hong, M. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,003
Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939
Alonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0796-783 · Cited by 859
Self-citationAlonso, A. D. C., Zaidi, T., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 827
Self-citationBancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Self-citationKöpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779
Self-citationRole of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738
Self-citationHydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.
Greenberg, S. G., Davies, P., Schein, J. D., & Binder, L. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48531-6 · Cited by 543
Himmler, A., Drechsel, D., Kirschner, M. W., & Martin, D. W. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1381 · Cited by 535
Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527
Self-citationD’Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V. M.-Y., Bird, T. D., & Schellenberg, G. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5598 · Cited by 515
Tau filament formation in transgenic mice expressing P301L tau
Götz, J., Chen, F., Barmettler, R., & Nitsch, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006531200 · Cited by 495
Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly
Hasegawa, M., Smith, M. J., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01217-4 · Cited by 483
Alonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437
Self-citationRizzu, P., Van Swieten, J. C., Joosse, M., Hasegawa, M., Stevens, M., Tibben, A., Niermeijer, M. F., Hillebrand, M., Ravid, R., Oostra, B. A., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302256 · Cited by 427
Schweers, O., Mandelkow, E. M., Biernat, J., & Mandelkow, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8463 · Cited by 334
Khatoon, S., Grundke‐Iqbal, I., & Iqbal, K. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09432.x · Cited by 304
Self-citationAccelerated filament formation from tau protein with specific FTDP‐17 missense mutations
Nacharaju, P., Lewis, J., Easson, C., Yen, S., Hackett, J., Hutton, M., & Yen, S.-H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00294-x · Cited by 283
Tatebayashi, Y., Miyasaka, T., Chui, D.-H., Akagi, T., Mishima, K.-I., Iwasaki, K., Fujiwara, M., Tanemura, K., Murayama, M., Ishiguro, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202205599 · Cited by 272
Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease.
Iqbal, K., Grundke-Iqbal, I., Smith, A. J., George, L., Tung, Y. C., & Zaidi, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5646 · Cited by 260
Self-citationEffects of frontotemporal dementia FTDP‐17 mutations on heparin‐induced assembly of tau filaments
Goedert, M., Jakes, R., & Crowther, R. A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00508-6 · Cited by 260
Neurodegeneration with Tau Accumulation in a Transgenic Mouse Expressing V337M Human Tau
Tanemura, K., Murayama, M., Akagi, T., Hashikawa, T., Tominaga, T., Ichikawa, M., Yamaguchi, H., & Takashima, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00133.2002 · Cited by 233
Tau-Mediated Cytotoxicity in a Pseudohyperphosphorylation Model of Alzheimer's Disease
Fath, T., Eidenmüller, J., & Brandt, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09733.2002 · Cited by 227
Bird, T. D., Nochlin, D., Poorkaj, P., Cherrier, M., Kaye, J., Payami, H., Peskind, E., Lampe, T. H., Nemens, E., Boyer, P. J., et al. (1999) · Brain · doi:10.1093/brain/122.4.741 · Cited by 222
Abnormal Tau-Containing Filaments in Neurodegenerative Diseases
Crowther, R. A., & Goedert, M. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4270 · Cited by 185
Tau gene mutations: dissecting the pathogenesis of FTDP-17
Ingram, E. M., & Spillantini, M. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02440-1 · Cited by 177
Wang, J., Grundke, I., & Iqbal, K. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00316-k · Cited by 175
Self-citationdel C. Alonso, A., Zaidi, T., Novak, M., Barra, H. S., Grundke-Iqbal, I., & Iqbal, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105365200 · Cited by 160
Self-citationFormation of Filamentous Tau Aggregations in Transgenic Mice Expressing V337M Human Tau
Tanemura, K., Akagi, T., Murayama, M., Kikuchi, N., Murayama, O., Hashikawa, T., Yoshiike, Y., Park, J., Matsuda, K., Nakao, S., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0439 · Cited by 146
Ultrastructure of Paired Helical Filaments of Alzheimerʼs Neurofibrillary Tangle
Wísniewski, H. M., MERZ, P. A., & Iqbal, K. (1984) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198411000-00008 · Cited by 126
Self-citationThe regulation of phosphorylation of τ in SY5Y neuroblastoma cells: the role of protein phosphatases
Tanaka, T., Zhong, J., Iqbal, K., Trenkner, E., & Grundke, I. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00346-9 · Cited by 118
Self-citationTatebayashi, Y., Iqbal, K., & Grundke, I. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05245.1999 · Cited by 107
Self-citationClinical features of frontotemporal dementia due to the intronic tau 10 +16 mutation
Janssen, J. C., Warrington, E. K., Morris, H. R., Lantos, P. L., Brown, J., Révész, T., Wood, N. W., Khan, M. N., Cipolotti, L., Fox, N. C., et al. (2002) · Neurology · doi:10.1212/wnl.58.8.1161 · Cited by 92
Singh, T. J., Haque, N., Grundke, I., & Iqbal, K. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01445-7 · Cited by 92
Self-citationLáng, E., Szendrei, G. I., Lee, V. M. ‐., & Ötvös, L. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91264-q · Cited by 86
Polymerization of Microtubule-associated Protein Tau under Near-physiological Conditions
Wilson, D. M., & Binder, L. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24306 · Cited by 81
The FTDP‐17‐Linked Mutation R406W Abolishes the Interaction of Phosphorylated Tau with Microtubules
Pérez, M., Lim, F., Arrasate, M., & Ávila, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742583.x · Cited by 80
Goldbaum, O., Oppermann, M., Handschuh, M., Dabir, D. V., Zhang, B., Forman, M. S., Trojanowski, J. Q., Lee, V. M. ‐., & Richter‐Landsberg, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08872.2003 · Cited by 80
Miyamoto, K., Kowalska, A., Hasegawa, M., Tabira, T., Takahashi, K., Araki, W., Akiguchi, I., & Ikemoto, A. (2001) · Annals of Neurology · doi:10.1002/ana.1083 · Cited by 79
Matsumura, N., Yamazaki, T., & Ihara, Y. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65420-x · Cited by 76
In Vitro Assembly of Tau Protein: Mapping the Regions Involved in Filament Formation
Pérez, M., Arrasate, M., de Garcini, E. M., Muñoz, V., & Ávila, J. (2001) · Biochemistry · doi:10.1021/bi002961w · Cited by 74
Functional effects of tau gene mutations ΔN296 and N296H
Yoshida, H., Crowther, R. A., & Goedert, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00729.x · Cited by 56
Krishnamurthy, P., & Johnson, G. V. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311203200 · Cited by 53
Neuropathologic variation in frontotemporal dementia due to the intronic tau 10 +16 mutation
Lantos, P. L., Cairns, N. J., Khan, M. N., King, A., Révész, T., Janssen, J. C., Morris, H. R., & Rossor, M. N. (2002) · Neurology · doi:10.1212/wnl.58.8.1169 · Cited by 51
Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins
Jicha, G. A., Rockwood, J. M., Berenfeld, B., Hutton, M., & Davies, P. J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00980-x · Cited by 46
Gene expression profiling of the tau mutant (P301L) transgenic mouse brain
Ho, L., Xiang, Z., Mukherjee, P., Zhang, W., Jesus, N. D., Mirjany, M., Yemul, S., & Pasinetti, G. M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02044-4 · Cited by 32
Mack, T. G. A., Dayanandan, R., van Slegtenhorst, M., Whone, A. L., Hutton, M. L., Lovestone, S., & Anderton, B. H. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00434-1 · Cited by 29
Detection of tubulin-binding proteins by an overlay assay
Kremer, L., Domínguez, J. E., & Ávila, J. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90365-x · Cited by 18
Bovine and human tau, highly homologous but less crossreactive: implications for Alzheimer disease
Alonso, A. D. C., Grundke, I., & Iqbal, K. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00051-s · Cited by 16
Self-citation
Cited by
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Tau in Alzheimer Disease and Related Tauopathies
Iqbal, K., Liu, F., Gong, C.-X., & Grundke-Iqbal, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,127
Self-citationRoles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037
“Four of these missense mutations, G272V, P301L, V337M and R406W, which have been studied to date, make tau a more favorable substrate than the wild-type human tau for abnormal hyperphosphorylation by brain protein kinases in vitro [36].”
BackgroundInfluential
Metadata
- Authors
- Alonso, A. D. C., Mederlyova, A., Novak, M., Grundke-Iqbal, I., & Iqbal, K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 279
- Issue
- 33
- Pages
- 34873-34881
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2059501379
- Cited by
- 329
- References
- 62
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.